Kaken Pharmaceuticals and ChemDiv, Inc. Partner in Drug Discovery Deal
2/26/2007 12:21:25 PM
More...
|
Kaken Pharmaceuticals To License Its Antifungal Compound KP-103 To Dow Pharmaceutical Sciences
5/11/2006 3:18:58 PM
More...
|
Kaken Pharmaceuticals Reveals Results From Early Phase II Clinical Trial On KCB-1D
10/19/2005 5:11:54 PM
More...
|
Kaiser Health Plan And Hospitals Continue Solid Financial Performance
10/19/2005 5:11:20 PM
More...
|
Kaken Pharmaceuticals Obtains Additional Approval For Its Anti-Osteoarthritic Agents
10/19/2005 5:09:51 PM
More...
|